KA
Closed
Kineta Inc.
0.4801
-0.0422 (-8.08%)
Last Update: 20 Nov 2024 17:30:00
Yesterday: 0.5223
Day's Range: 0.4801 - 0.5223
Send
sign up or login to leave a comment!
When Written:
3.25
Kineta Inc. is a biotechnology company that is focused on the development of novel immunotherapies and drugs for the treatment of autoimmune diseases, chronic pain, and viral infections. The company was founded in 2007 and is headquartered in Seattle, Washington.
Kineta's lead drug candidate is KCP506, which is being developed for the treatment of chronic pain. The company is also developing a range of other drug candidates, including immunotherapies for the treatment of autoimmune diseases and antiviral drugs for the treatment of viral infections.
Kineta has partnerships with several pharmaceutical companies, including Pfizer and Genentech. The company has also received funding from the National Institutes of Health (NIH) and the Department of Defense (DOD) to support its research and development efforts.
Overall, Kineta is a biotechnology company that is focused on developing innovative therapies for a range of diseases and conditions. Its research and development efforts are supported by partnerships with leading pharmaceutical companies and funding from government agencies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Kineta's lead drug candidate is KCP506, which is being developed for the treatment of chronic pain. The company is also developing a range of other drug candidates, including immunotherapies for the treatment of autoimmune diseases and antiviral drugs for the treatment of viral infections.
Kineta has partnerships with several pharmaceutical companies, including Pfizer and Genentech. The company has also received funding from the National Institutes of Health (NIH) and the Department of Defense (DOD) to support its research and development efforts.
Overall, Kineta is a biotechnology company that is focused on developing innovative therapies for a range of diseases and conditions. Its research and development efforts are supported by partnerships with leading pharmaceutical companies and funding from government agencies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








